Melatoninergic Antidepressant in Post-Stroke Depression Therapy

HTML  XML Download Download as PDF (Size: 1042KB)  PP. 29-38  
DOI: 10.4236/aar.2018.72003    1,236 Downloads   2,488 Views  Citations

ABSTRACT

This paper presents the results of the effects of Melitor (25 mg during two months) on the psychic-emotional state, cerebral hemodynamic and bioelectrical activity of the brain in 30 patients (average age 66.2 ± 3.2 years) with ischemic post-stroke depression. It has been found that this drug possesses a multimodal action which is characterized by the decrease of the level of depression, widening of the range of social-environmental activity, improvement of the cerebral blood circulation and harmonization of the brain electrogenesis. In the patients with right versus left hemisphere stroke, the effect of Melitor on the functional state of the brain was more pronounced. Based on the results obtained in our study, we can recommend Melitor to use it in complex scheme of rehabilitation care of patients of the given nosological category.

Share and Cite:

Kuznetsov, V. (2018) Melatoninergic Antidepressant in Post-Stroke Depression Therapy. Advances in Aging Research, 7, 29-38. doi: 10.4236/aar.2018.72003.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.